Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04144036
Recruitment Status : Recruiting
First Posted : October 30, 2019
Last Update Posted : September 16, 2021
Sponsor:
Information provided by (Responsible Party):
Sameem M. Abedin, MD, Medical College of Wisconsin

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 1, 2022
Estimated Study Completion Date : February 1, 2023